Health Rising’s Quickie Summer 2026 Donation Drive

15000

14435

HEALTH RISING IS NOT A 501 (c) 3 NON-PROFIT

Takeaways From the Big Long COVID Clinical Trials

Takeaways From the Big Long COVID Clinical Trials

by | Apr 21, 2026 | Amytriptyline, Antivirals, CoQ10, COVID-19, Homepage, Inflammation, Ivabradine, Klimas, Lipids, long COVID, Mast cell activation syndrome, Microbiome, Orthostatic intolerance, Paxlovid, POTS, Treatment

Only 10 major long COVID clinical trials have been published thus far but that's enough to come away with some interesting takeaways. They include treatments that prevent long COVID don't necessarily treat it, broader based treatments are probably best, manipulating the gut can help with fatigue (but only so much), and an as yet unassessed class of drugs may be helpful.
“Invisible No More”: Exploring Dr. Ruhoy’s New Treatment Guide for ME/CFS, Long COVID, etc.

“Invisible No More”: Exploring Dr. Ruhoy’s New Treatment Guide for ME/CFS, Long COVID, etc.

by | Mar 23, 2026 | Alternative Health, Connective Tissues, CoQ10, Cryotherapy, Doctors, Exercise, Herbs and Botanicals, Homepage, L-carntine/Acetylcarnitine, long COVID, Low Dose Naltrexone, Mast cell activation syndrome, ME/CFS, Mind/body, Neuroplasticity, Physical Therapy, Plasmapheresis, Psychedelics, Red Light Therapy, Ruhoy, Sleep, Spine, Treatment, Urolithin A

An in-depth exploration of Dr. Ruhoy's treatment guide "Invisible No More" for ME/CFS, long COVID and similar diseases
Blood, Sex and Inflammation: Did the IMPACC Study Uncover Core Issues in Long COVID and ME/CFS?

Blood, Sex and Inflammation: Did the IMPACC Study Uncover Core Issues in Long COVID and ME/CFS?

by | Mar 5, 2026 | Baricitinib, Cardiovascular, Clotting, Complement, COVID-19, Endothelial Cells, Energy Production, Homepage, Hypoxia, Inflammation, Klimas, long COVID, Metabolism, Muscles, Oxidative Stress, Proteomics

The big IMPACC long COVID study findings suggest that inflammation and reduced male sex hormone levels may be playing havoc with the small blood vessels in long COVID -= and ME/CFS
Low Brain Norepinephrine Levels in ME/CFS and Long COVID Pt. II: A ChatGPT Based Treatment Program

Low Brain Norepinephrine Levels in ME/CFS and Long COVID Pt. II: A ChatGPT Based Treatment Program

by | Nov 16, 2025 | Autonomic Nervous System, Brain, Brainstem, Clonidine, CoQ10, D-Ribose, GLP-1, GLP-1 agonist, Guanfacine, Homepage, Ivabradine, Kaiser, L-carntine/Acetylcarnitine, Locus coeruleus, Mast cell activation syndrome, Mestinon, Neuroplasticity, Neuroplasticity, Norepinephrine, Pacing, Prefrontal Cortex, Propanolol, Rapamycin, Research, Stimulants, Urolithin A

Check out how ChatGPT thinks people with ME/CFS and long COVID might treat the low norepinephine brain findings in these diseases.
The GLP-1 Agonist Boom in ME/CFS, FM and Long COVID: Insights, Using it, Trials Underway

The GLP-1 Agonist Boom in ME/CFS, FM and Long COVID: Insights, Using it, Trials Underway

by | Nov 3, 2025 | COVID-19, Dempsey, Epstein-Barr Virus, GLP-1, Gut, Homepage, Immune, Inflammation, Kaufman, Mast cell activation syndrome, Mast cell activation syndrome, Neuroinflammation, Pathogens, POTS, RECOVER Initiative, Severe ME/CFS, Treatment

Complex, chronic illness experts discuss what GLP-1 agonists can and can't do in diseases like ME/CFS, long COVID, and POTS. Plus new long COVID trials.
Please support Health Rising in our Quickie Summer Donation Drive! Our goal is $15,000.Click here for more.

Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News

Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities. 

Thank you for signing up!

Pin It on Pinterest